BioSpace News Archive

To help customers with an accelerated route to market for 3D printed PAEK parts, UK-based Victrex has commenced a multi-million Euro investment in Bond High Performance 3D Technology.

Leonhardt’s Launchpads, a Los Angeles, Salt Lake City and Pittsburgh based innovation and startup accelerator focused on bioelectric and biologics based organ regeneration and recovery, today announced filing of patent application for bioelectrical stimulation signaling sequences able to control the release of Klotho,

SynergEyes, Inc., a leader in specialty contact lens technology, announces that the SynergEyes VS scleral lens is now available with Tangible Hydra-PEG on Contamac material

Delivering Significant Progress with Drug Pipeline Development, Commercialization Readiness and Operation Excellence

Contextual Genomics, a leading Canadian cancer genomics company, announced that its Board of Directors has named Michael Ball as Chief Executive Officer.

-Biohaven remains on-track for new drug application (NDA) submission for rimegepant Zydis ODT and tablet formulation in 2Q2019

Groundbreaking Technology Delivers Accurate Results Clinicians Rely On and Trust While Simplifying Workflow and Improving Turnaround Time

Rapid Tension Relief now available exclusively at Massage Envy franchises nationwide

Deerfield commits $100M to inject fuel into translational life science research at Harvard

Sekhmet Ventures, a newly-formed venture capital firm in the beauty and wellness market, announced the appointment of Sara Kaur as its Chief Financial Officer.